WEBINAR ENDED
WEBINAR DETAILS
  • When
    Add to calendar
  • About
    Based on the publication of the Q2 2020 Interim Report earlier the same day, the senior Management Team will offer a walkthrough of the report contents and answer questions from the audience.

    Pre-submitted questions will be prioritized. To submit a question, please send it to webcast@oncologyventure.com, no later than 3 pm on 28 August.

    Oncology Venture is building a personalized medicine company developing new therapeutics for unmet needs in the treatment of human cancers through the use of the company's world-class predictive diagnostics platform.
  • Agenda
    • CEO's presentation by Steve Carchedi
    • Financials by CFO Henrik Moltke
    • Q&A
  • Duration
    45 minutes
  • Price
    Free
  • Language
    English
  • OPEN TO
    Anyone with the event link can attend
  • Dial-in Number
    +1 (312) 248-9348
  • Dial-in ID Number
    #
  • Dial-in Passcode
    2150#
FEATURED PRESENTERS
  • Webinar hosting presenter

    Steve Carchedi

    CEO and Member of the Board of Directors, Oncology Venture A/S
    30+ years of commercial industry experience focused in oncology, including former CEO roles at Apexian Pharmaceuticals, Raphael Pharmaceuticals (formerly Cornerstone Pharmaceuticals), and Senior Vice President and President, Commercial Operations...
    Full Profile
  • Webinar hosting presenter

    Henrik Moltke

    CFO, Oncology Venture A/S
    30+ years of experience in the life sciences industry serving on executive teams, including numerous CFO roles. He was a Co-Founder of NeuroSearch A/S, has raised more than 2 billion DKK in investment for life science companies, and has...
    Full Profile
ATTENDED (251)
Powered by BigMarker